Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncology and Therapy|February 17, 2023
Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview StudyDanielle E Altman, Xinke Zhang, An-Chen Fu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2020
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 AssayHans Juergen Grote, Zheng Feng, Michael Schlichting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST studyEric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, et al.
Cancer Immunology, Immunotherapy : CII|February 6, 2019
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinomaSandra P D'Angelo, Matthias Hunger, Andrew S Brohl, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2Matthew Wortham, Bastian Ramms, Chun Zeng, et al.
The New England Journal of Medicine|April 3, 2009
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancerEric Van Cutsem, Claus-Henning Köhne, Erika Hitre, et al.
Developmental Cell|May 24, 2025
Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoidsYesl Jun, Kim-Vy Nguyen-Ngoc, Somesh Sai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib StudyAndrea B Apolo, Jeffrey R Infante, Ani Balmanoukian, et al.
Pageof 4